Tech article
PVX-001: open-source Covid-19 vaccine starts Phase 1 trial
No preview is available. Read the original article for the full story.
Hacker News | Oct 10, 2026 | jajoosam
Automated excerpt
What an insane fucking ride this has been. I’ve waited 5 years to write these words: On 31 August 2026, the first two participants each received a dose of PVX-001, our broadly-protective COVID-19 vaccine candidate designed to protect against future variants of SARS-CoV-2 that may emerge, in a first-in-human Phase I clinical trial in Melbourne, Australia (ACTRN12626000891325).
Selected automatically from source text; not independently written or fact-checked. Read the original for full context.